Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Sameet Chavan of Angel Broking is of the view that one may buy Gail India with a target of Rs 375.
Manas Jaiswal of manasjaiswal.com is of the view that one can buy ILandFS Investment Managers with a target of Rs 20 and Piramal Enterprises with a target of Rs 1210.
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com spoke about his outlook on the market and specific stocks.
Prakash Gaba of prakashgaba.com recommends going long in Bharat Electronics and feels that Dabur India may hit Rs 280.
Ashwani Gujral of ashwanigujral.com recommends buying Oil and Natural Gas Corporation, Dabur India and Oil India.
Ashwani Gujral of ashwanigujral.com is of the view that one can sell Dabur India and Bajaj Finance and advises buying Ceat.
The brokerage firm adds that Dabur is best placed to extend its core product portfolio with forecasts of a normal monsoon rains.
Ashwani Gujral of ashwanigujral.com is of the view that one can sell Voltas and Dabur India and advises selling Glenmark Pharma.
Ashwani Gujral of ashwanigujral.com recommends buying Dabur India and advises selling Havells India and Ambuja Cements.
Vijay Chopra of enochventures.com is of the view that one may exit Marksans Pharma.
Watch the interview of SP Tulsian of sptulsian.com with Latha Venkatesh and Sonia Shenoy on CNBC-TV18, in which he shared his reading and outlook on the fundamentals of the market, specific stocks and sectors.
Sudarshan Sukhani of s2analytics.com recommends buying Dabur India and Walchandnagar Industries.
Ashwani Gujral of ashwanigujral.com recommends buying Dabur India, Wockhardt and Petronet LNG.
Shahina Mukadam, Independent Market Expert is of the view that one may buy Tata Power with a target of Rs 69.5.
Sudarshan Sukhani of s2analytics.com advises buying Power Grid, Dabur and Hero Motocorp.
Sarvendra Srivastava of Phisense.com advises buying Arvind with a target of Rs 271.9.
Rajat Bose of rajatkbose.com is of the view that one can sell Bharat Forge and Britannia Industries.
Sudarshan Sukhani of s2analytics.com recommends buying Adani Ports and Dabur India.
Ashwani Gujral of ashwanigujral.com recommends buying Cairn India, Welspun India and Dabur India.
Ashwani Gujral of ashwanigujral.com recommends buying Dabur India, LIC Housing, Adani Ports, BPCL and M&M Financial Services.
Ashwani Gujral of ashwanigujral.com is of the view that one can sell Mahindra & Mahindra Financial Services and Dabur India and advises buying Apollo Tyres.
Siddarth Bhamre of Angel Broking recommends going long in Cipla and Dabur India.
Manish Sharma of derivativetradingresearch.com suggests buying Just Dial with a target of Rs 580.
Credit Suisse says that Patanjali's impact was clearly visible in October-December quarter with Colgate seeing flat volumes on annual basis and Dabur seeing a revenue decline in its health supplements business.
Sudarshan Sukhani of s2analytics.com recommends buying Hindustan Unilever, Dabur India and Sun Pharma.